Intravenous Iron Drugs Market – By Drug Type (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose), Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer), Distribution Channel (Hospital, Retail, Online) – Global Forecast 2024 – 2032
Report ID: GMI10898
|
Published Date: August 2024
|
Report Format: PDF
Download Free PDF
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 15
Tables & Figures: 219
Countries covered: 23
Pages: 132
Download Free PDF

Intravenous Iron Drugs Market
Get a free sample of this reportGet a free sample of this report Intravenous Iron Drugs Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Intravenous Iron Drugs Market Size
Intravenous Iron Drugs Market size was valued at around USD 1.7 billion in 2023 and is estimated to grow at 6.7% CAGR from 2024 to 2032. Intravenous (IV) iron drugs are pharmaceutical formulations of iron administered directly into the bloodstream through intravenous injection or infusion. These drugs are used to treat or prevent iron deficiency anemia, particularly in patients who cannot absorb oral iron supplements effectively or who have conditions that require rapid replenishment of iron stores.
The rising prevalence of chronic diseases such as chronic kidney disease (CKD), cancer, and inflammatory disorders are significant driving factors for the market. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million cancer-related deaths worldwide. This underscores the critical need for effective treatment options, including intravenous iron therapies, to manage anemia associated with these conditions and improve patient outcomes.
Furthermore, increasing awareness of the timely diagnosis of iron deficiencies, a growing geriatric population, and advancements in IV iron drug formulations are also contributing to revenue growth in the market.
Intravenous Iron Drugs Market Trends
Advancements in intravenous (IV) iron drug formulations have significantly transformed the landscape of iron deficiency treatment. Recent innovations focus on enhancing the safety, efficacy, and convenience of these therapies.
Intravenous Iron Drugs Market Analysis
Based on drug type, the market is segmented into iron dextran, iron sucrose, ferric carboxymaltose, and other drug types. The ferric carboxymaltose segment of the market is forecasted to reach USD 1.5 billion by 2032.
Based on application, the intravenous iron drugs market is segmented into chronic kidney disease, inflammatory bowel disease, cancer, and other applications. The chronic kidney disease segment accounted for USD 1 billion in 2023.
Based on distribution channel, the intravenous iron drugs market is bifurcated into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is forecasted to reach USD 1.4 billion by 2032.
The growth of the intravenous iron drugs market in the U.S. is projected to reach USD 1 billion by 2032.
The intravenous iron drugs market in UK is expected to experience significant and promising growth from 2024 to 2032.
Japan intravenous iron drugs market is anticipated to witness lucrative growth between 2024 – 2032.
The market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
Intravenous Iron Drugs Market Share
The market is highly competitive, with a mix of major global companies and smaller to medium-sized firms vying for market share. A key aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. These leading companies play a crucial role in shaping the market's trajectory. In addition to research and development efforts, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding the global footprint of prominent players. Meanwhile, smaller companies focus on specific drug types to compete with established vendors.
Intravenous Iron Drugs Market Companies
Some of the eminent market participants operating in the intravenous iron drugs industry include:
Intravenous Iron Drugs Industry News:
The intravenous iron drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Drug Type
Market, By Application
Market, By Distribution Channel
The above information is provided for the following regions and countries: